SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-028201
Filing Date
2021-05-17
Accepted
2021-05-17 08:37:07
Documents
4
Period of Report
2021-05-17

Document Format Files

Seq Description Document Type Size
1 6-K lmnl-6k_20210517.htm 6-K 23935
2 EX-99.1 lmnl-ex991_6.htm EX-99.1 44611
3 GRAPHIC gunn1pm0qscq000001.jpg GRAPHIC 2579
4 GRAPHIC gp4ev4y4vh5r000001.jpg GRAPHIC 38195
  Complete submission text file 0001564590-21-028201.txt   126101
Mailing Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4
Business Address 440 BOULEVARD ARMAND FRAPPIER #300 LAVAL A8 H7V 4B4 450-781-0115
Liminal BioSciences Inc. (Filer) CIK: 0001351172 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39131 | Film No.: 21927796
SIC: 2834 Pharmaceutical Preparations